Search Results 31-40 of 17321 for egfr
... (EGFR)-Mutated Locally Advanced Or Metastatic Non-Small Cell Lung Cancer (NSCLC). Print details. Share; Facebook · Twitter. Overview; Participation eligibility ...
Older versions of contrast agents that contain gadolinium increase the risk of a rare but serious disease called nephrogenic systemic fibrosis. This disease ...
Additional patients limited to those with EGFR mutations may be enrolled following the initial study period as needed to ensure adequate sample sizes needed to ...
A Study To Evaluate The Safety And Efficacy Of A2B395, An Allogeneic Logic-gated CAR T, In Participants With Solid Tumors That Express EGFR And Have Lost HLA-A* ...
Participation eligibility · Diagnosis: Histological confirmation of either glioblastoma, IDH wildtype (GBM) or anaplastic astrocytoma, IDH wildtype (AA); · EGFR ...
Determine the presence or absence of interspecies cells in xenograft or chimeric animal models. Fluorescence in situ hybridization of a locus-specific EGFR ...
About this study. The purpose of this study is to test specific analytical performance characteristics of the beta trace protein (BTP) assay on the BN ...
Discover the critical link between diabetes and chronic kidney disease. Learn more from a Mayo Clinic expert on the link.
... EGFR or ALK gene. It is also used to treat metastatic non-small cell lung cancer with or without an EGFR or ALK gene in patients who have tried treatment for ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!